Do We Have a "game Changer" in Treating Patients with Brain Metastasis from Renal Cell Carcinoma?

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Feb 5

PMID 32016078

Citations 6

Authors

Olga Vornicova

Gil Bar-Sela

Affiliations

Soon will be listed here.

Citing Articles

Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma.

Baston C, Parosanu A, Stanciu I, Nitipir C Biomedicines. 2024; 12(5).

PMID: 38791072 PMC: 11117570. DOI: 10.3390/biomedicines12051111.

Fatal tumoral hemorrhage from brain metastases of renal cell carcinoma after stereotactic radiotherapy and immune checkpoint inhibitor and vascular endothelial growth factor-targeted therapy combinations.

Iwasa K, Nakazawa S, Kato T, Hatano K, Kawashima A, Fukuhara S IJU Case Rep. 2024; 7(3):225-229.

PMID: 38686061 PMC: 11056256. DOI: 10.1002/iju5.12708.

Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.

Baston C, Parosanu A, Mihai M, Moldoveanu O, Stanciu I, Nitipir C Diagnostics (Basel). 2024; 14(5).

PMID: 38473025 PMC: 10930794. DOI: 10.3390/diagnostics14050553.

The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm.

Le Y, Xu W, Guo W Technol Cancer Res Treat. 2023; 22:15330338231165131.

PMID: 37078130 PMC: 10126632. DOI: 10.1177/15330338231165131.

Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.

Emamekhoo H, Olsen M, Carthon B, Drakaki A, Percent I, Molina A Cancer. 2021; 128(5):966-974.

PMID: 34784056 PMC: 9298991. DOI: 10.1002/cncr.34016.

References

Patchell R, Tibbs P, Walsh J, Dempsey R, Maruyama Y, Kryscio R . A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322(8):494-500. DOI: 10.1056/NEJM199002223220802. View

Chevreau C, Ravaud A, Escudier B, Amela E, Delva R, Rolland F . A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases. Clin Genitourin Cancer. 2013; 12(1):50-4. DOI: 10.1016/j.clgc.2013.09.008. View

Bindal R, Sawaya R, LEAVENS M, Lee J . Surgical treatment of multiple brain metastases. J Neurosurg. 1993; 79(2):210-6. DOI: 10.3171/jns.1993.79.2.0210. View

Sivasanker M, Madhugiri V, Moiyadi A, Shetty P, Subi T . Surgery for brain metastases: An analysis of outcomes and factors affecting survival. Clin Neurol Neurosurg. 2018; 168:153-162. DOI: 10.1016/j.clineuro.2018.03.011. View

Choi S, Yoo S, You D, Jeong I, Song C, Hong B . Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma. Clin Genitourin Cancer. 2017; 15(6):717-723. DOI: 10.1016/j.clgc.2017.05.010. View

Vrana D, Studentova H, Matzenauer M, Vlachova Z, Cwiertka K, Gremlica D . Treatment of brain metastases of renal cell cancer with combined hypofractionated stereotactic radiotherapy and whole brain radiotherapy with hippocampal sparing. Oncol Lett. 2016; 11(6):3777-3781. PMC: 4888132. DOI: 10.3892/ol.2016.4440. View

Hanson P, Elaimy A, Lamoreaux W, Demakas J, Fairbanks R, Mackay A . A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol. 2012; 10:176. PMC: 3502222. DOI: 10.1186/1477-7819-10-176. View

Peverelli G, Raimondi A, Ratta R, Verzoni E, Bregni M, Cortesi E . Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population. Clin Genitourin Cancer. 2019; 17(4):291-298. DOI: 10.1016/j.clgc.2019.05.002. View

Wardak Z, Christie A, Bowman A, Stojadinovic S, Nedzi L, Barnett S . Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma. Clin Genitourin Cancer. 2019; 17(2):e273-e280. PMC: 6563340. DOI: 10.1016/j.clgc.2018.11.006. View

10.

Tawbi H, Forsyth P, Algazi A, Hamid O, Hodi F, Moschos S . Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. N Engl J Med. 2018; 379(8):722-730. PMC: 8011001. DOI: 10.1056/NEJMoa1805453. View

11.

Gore M, Hariharan S, Porta C, Bracarda S, Hawkins R, Bjarnason G . Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer. 2010; 117(3):501-9. DOI: 10.1002/cncr.25452. View

12.

Flippot R, Dalban C, Laguerre B, Borchiellini D, Gravis G, Negrier S . Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study. J Clin Oncol. 2019; 37(23):2008-2016. DOI: 10.1200/JCO.18.02218. View

13.

Doh L, Amato R, Paulino A, Teh B . Radiation therapy in the management of brain metastases from renal cell carcinoma. Oncology (Williston Park). 2006; 20(6):603-13. View

14.

Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R . Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol. 2010; 186(4):210-7. DOI: 10.1007/s00066-010-2055-z. View

15.

Janzen N, Kim H, Figlin R, Belldegrun A . Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003; 30(4):843-52. DOI: 10.1016/s0094-0143(03)00056-9. View

16.

Rades D, Heisterkamp C, Schild S . Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?. Int J Radiat Oncol Biol Phys. 2010; 78(2):398-403. DOI: 10.1016/j.ijrobp.2009.08.022. View

17.

Vickers M, Al-Harbi H, Choueiri T, Kollmannsberger C, North S, MacKenzie M . Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium. Clin Genitourin Cancer. 2013; 11(3):311-5. DOI: 10.1016/j.clgc.2013.04.012. View

18.

Staehler M, Haseke N, Nuhn P, Tullmann C, Karl A, Siebels M . Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. BJU Int. 2010; 108(5):673-8. DOI: 10.1111/j.1464-410X.2010.09895.x. View

19.

Elaimy A, Mackay A, Lamoreaux W, Fairbanks R, Demakas J, Cooke B . Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors. World Neurosurg. 2011; 75(5-6):673-83. DOI: 10.1016/j.wneu.2010.12.006. View

20.

Shuch B, La Rochelle J, Klatte T, Riggs S, Liu W, Kabbinavar F . Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer. 2008; 113(7):1641-8. DOI: 10.1002/cncr.23769. View